000 01344 a2200361 4500
005 20250515223026.0
264 0 _c20110512
008 201105s 0 0 eng d
022 _a1742-1241
024 7 _a10.1111/j.1742-1241.2009.02239.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlbertson, T E
245 0 0 _aFluoroquinolones in the management of community-acquired pneumonia.
_h[electronic resource]
260 _bInternational journal of clinical practice
_cFeb 2010
300 _a378-88 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnti-Bacterial Agents
_xpharmacokinetics
650 0 4 _aCommunity-Acquired Infections
_xdrug therapy
650 0 4 _aFluoroquinolones
_xpharmacokinetics
650 0 4 _aHumans
650 0 4 _aPneumonia, Bacterial
_xdrug therapy
650 0 4 _aPractice Guidelines as Topic
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aRisk Factors
650 0 4 _aTreatment Outcome
700 1 _aDean, N C
700 1 _aEl Solh, A A
700 1 _aGotfried, M H
700 1 _aKaplan, C
700 1 _aNiederman, M S
773 0 _tInternational journal of clinical practice
_gvol. 64
_gno. 3
_gp. 378-88
856 4 0 _uhttps://doi.org/10.1111/j.1742-1241.2009.02239.x
_zAvailable from publisher's website
999 _c19811318
_d19811318